Investments, Press Release

Lygos bags $13m funding

Lygos, Inc., a bio-based specialty chemicals company, announced last week the closing of $13 million in Series A financing led by IA Ventures and OS Fund. Other investors include First Round Capital, the Y Combinator Continuity Fund, 50 Years and Vast Ventures, along with notable angel investors.

Lygos has pioneered the world’s first bio-based production of malonic acid. Lygos has already engineered and is shipping to customers metric ton quantities of its Bio-malonic™ acid. Lygos said it has created an engineering development platform that combines software and new biochemistry technology to engineer microbes optimized to produce the industry’s highest-quality specialty chemicals at scale much faster, safer, and more reliably than traditional petroleum-based production methods.

Just a reminder to Tecnon OrbiChem Biomaterials subscribers, we have a more comprehensive report on malonic acid in our May 2016 issue (#33).

About Doris de Guzman

Will Green Chemistry save the world or is it hype? Doris de Guzman examines alternative processing, new technology, R&D and other sustainability initiatives aimed at preventing pollution; replacing ingredients; and using renewable feedstocks in Green Chemistry. She has been covering the oleochemicals market for 15 years and spread her beat to inorganics, biofuels and green chemistry.


Comments are closed.

Confirm if you are currently a subscriber to Tecnon OrbiChem's Bio-Materials newsletter. If not, please contact


Follow me on Twitter

%d bloggers like this: